Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells

Cancer

Volumn 77, Issue 8 SUPPL., 1996, Pages 1717-1721

  Itoh, Fumio ^a,b   Yamamoto, Hiroyuki ^a   Hinoda, Yuji ^a   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b First Dept of Internal Medicine   (Japan)

Author keywords

colorectal cancer; colorectal carcinogenesis; invasion; matrilysin; matrix metalloproteinase; zymography

Indexed keywords

CASEIN; COMPLEMENTARY DNA; ENZYME INHIBITOR; MATRILYSIN; MESSENGER RNA; METALLOPROTEINASE;

CANCER INVASION; CARCINOGENESIS; COLON CANCER; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; EPITHELIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0642339475     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19960415)77:8<1717::aid-cncr45>3.0.co;2-#     Document Type: Conference Paper

References (24)

1. Brikedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Brikedal-Hansen B, Decarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
2. Cockett MI, Birch ML, Murphy G, Hart IR, Docherty AJ. Metalloproteinase domain structure, cellular invasion and metastasis. Biochem Soc Trans 1994;22:55-7.
3. McDonnell S, Wright JH, Gaire M, Matrisian LM. Expression and regulation of stromelysin and matrilysin by growth factors and oncogenes. Biochem Soc Trans 1994;22:58-63.
4. Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995;55:1856-62.
5. Matrisian LM. Metalloproteinase and their inhibitor in matrix remodeling. Trends Genet 1990;6:121-5.
6. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
7. Quantin B, Murphy G, Breathnach R. Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry 1990;28:5327-34.
8. Miyazaki K, Hattori Y, Umenishi F, Yasumitu H, Umeda M. Purification and characterization of extracellular-matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res 1990;50:7758-64.
9. Woessner JF, Taplin C. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 1988;263:16918-25.
10. Baragi VM, Fliszar CJ, Conroy MC, YE QZ, Shipley JM, Welgus HG. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit compromised binding affinities as compared to full-length stromelysin. J Biol Chem 1994;269:12692-7.
11. Crabbe T, Smith B, O'Connel J, Docherty A. Human progelatinase A can be activated by matrilysin. FEBS Lett 1994;345:14-6.
12. Zhang Z, Winyard PG, Chidwick K, Murphy G, Wardell M, Carrell RW, et al. Proteolysis of human native and oxidized α1-proteinase inhibitor by matrilysin and stromelysin. Biochim Biophys Acta 1994;1199:224-8.
13. McDonnell S, Navre M, Coffey RJ, Matrisian LM. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog 1991;4:527-33.
14. Yoshimoto M, Itoh F, Yamamoto H, Hinoda Y, Imai K, Yachi A. Expression of MMP-7 (pump-1) mRNA in human colorectal cancers. Int J Cancer 1993;54:614-8.
15. Pyke C, Ralfkiar E, Tryggvason K, Dano K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993;142:359-64.
16. Porte H, Chastre E, Nordlinger B, Basset P, Herve De Sigalony JP, Prevost S, et al. Expression of the stromelysin 3 gene in human colonic adenocarcinomas and their liver metastasis [abstract]. Clin Exp Metastasis 1992;10:114.
17. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991, 5:2145-54.
18. Brown PD, Bioxidge RE, Stuart NSA, Gatter KC, Carmichael J. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 1993;85:574-8.
19. Mori M, Barnard GF, Mimori K, Ueo H, Akiyoshi T, Sugimachi K. Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer 1995;75:1516-9.
20. Nakajima M, Morikawa K, Fabra A, Bucana CD, Fidler IJ. Influence of organ environment on extracellular-matrix-degrading activity and metastasis of human colon-carcinoma cells. J Natl Cancer Inst 1990;82:1890-8.
21. Hendrix MJC, Seftor EA, Seftor REB, Fidler IJ. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett 1987;38:137-47.
22. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Turner DR. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumors. Int J Cancer 1991;49:666-72.
23. Lu X, Levy M, Weinstein B, Santella M. Immunological quantification of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer. Cancer Res 1991;51:6231-5.
24. Koshikawa N, Yasumitsu H, Umeda M, Miyazaki K. Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines. Cancer Res 1992;52:5046-53.